Position
Steadtrust LLC in AbbVie Inc.
Back to the book · All holders of ABBV
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$26.6K$228.50 → $217.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q2 2025 | 2.28K | $423.8K | — | — | — | 0.3% |
| Q3 2025 | 2.41K | $558.4K | $231.50 | $104.7K | $29.9K | 0.4% |
| Q4 2025 | 2.42K | $553K | $228.50 | −$7.23K | $1.83K | 0.3% |
| Q1 2026 | 2.42K | $527.4K | $217.50 | −$26.6K | $1.09K | 0.3% |